Trial · NCT01688921
Results by group57
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 57
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Anti Influenza Type A/H1N1 Hemagglutination Inhibition (HAI) Antibody Geometric Mean Titer (GMT) | PJ STRATIS | Day 0 | 4.43 | Standard Deviation 1.348 | Titers |
| Anti Influenza Type A/H1N1 Hemagglutination Inhibition (HAI) Antibody Geometric Mean Titer (GMT) | Needle-Syringe | Day 0 | 4.38 | Standard Deviation 1.352 | Titers |
| Anti Influenza Type A/H1N1 Hemagglutination Inhibition (HAI) Antibody Geometric Mean Titer (GMT) | PJ STRATIS | Day 28 | 5.64 | Standard Deviation 1.006 | Titers |
| Anti Influenza Type A/H1N1 Hemagglutination Inhibition (HAI) Antibody Geometric Mean Titer (GMT) | Needle-Syringe | Day 28 | 5.64 | Standard Deviation 0.997 | Titers |
| Anti Influenza Type A/H2N3 Hemagglutination Inhibition (HAI) Antibody Geometric Mean Titer (GMT) | PJ STRATIS | Day 0 | 4.22 | Standard Deviation 1.283 | Titers |
| Anti Influenza Type A/H2N3 Hemagglutination Inhibition (HAI) Antibody Geometric Mean Titer (GMT) | Needle-Syringe | Day 0 | 4.32 | Standard Deviation 1.290 | Titers |
| Anti Influenza Type A/H2N3 Hemagglutination Inhibition (HAI) Antibody Geometric Mean Titer (GMT) | PJ STRATIS | Day 28 | 5.51 | Standard Deviation 1.022 | Titers |
| Anti Influenza Type A/H2N3 Hemagglutination Inhibition (HAI) Antibody Geometric Mean Titer (GMT) | Needle-Syringe | Day 28 | 5.58 | Standard Deviation 0.987 | Titers |
| Anti Influenza Type B Hemagglutination Inhibition (HAI) Antibody Geometric Mean Titer (GMT) | PJ STRATIS | Day 0 | 2.60 | Standard Deviation 1.028 | Titers |
| Anti Influenza Type B Hemagglutination Inhibition (HAI) Antibody Geometric Mean Titer (GMT) | Needle-Syringe | Day 0 | 2.54 | Standard Deviation 1.003 | Titers |
| Anti Influenza Type B Hemagglutination Inhibition (HAI) Antibody Geometric Mean Titer (GMT) | PJ STRATIS | Day 28 | 3.75 | Standard Deviation 1.037 | Titers |
| Anti Influenza Type B Hemagglutination Inhibition (HAI) Antibody Geometric Mean Titer (GMT) | Needle-Syringe | Day 28 | 3.68 | Standard Deviation 1.061 | Titers |
| Anti Influenza Type A/H1N1 Seroconversion | PJ STRATIS | 37.5 | Percent of Participants | ||
| Anti Influenza Type A/H1N1 Seroconversion | Needle-Syringe | 38.4 | Percent of Participants | ||
| Anti Influenza Type A/H3N2 Seroconversion | PJ STRATIS | 43.8 | Percent of Participants | ||
| Anti Influenza Type A/H3N2 Seroconversion | Needle-Syringe | 45.1 | Percent of Participants | ||
| Anti Influenza Type B Seroconversion | PJ STRATIS | 34.9 | Percent of Participants | ||
| Anti Influenza Type B Seroconversion | Needle-Syringe | 35.2 | Percent of Participants | ||
| Number of Subjects With Complaints Within 30 Minutes Following Vaccination | PJ STRATIS | Pain | 163 | participants | |
| Number of Subjects With Complaints Within 30 Minutes Following Vaccination | Needle-Syringe | Pain | 69 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01688921/results